SCHEMBL18745825

SCHEMBL18745825

CCC(C)(CC)c1ccc(N2CCN(C(C)=O)CC2)nc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 7/20 0.56
▸ HPGD P15428 1/20 0.56
▸ AOC3 Q16853 1/20 0.52
▸ ALDH1A1 P00352 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ KDM4E B2RXH2 6/20 0.49
▸ POLB P06746 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ LMNA P02545 4/20 0.48
▸ ME2 P23368 3/20 0.48
▸ ME1 P48163 3/20 0.48
▸ ME3 Q16798 3/20 0.48
▸ MAPT P10636 4/20 0.48
▸ CKS1B P61024 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12412525 0.86 SMN1; SMN2 (0.54) SMN1; SMN2HPGDAOC3ALDH1A1L3MBTL1
SCHEMBL18711414 0.82 SMN1; SMN2 (0.70) SMN1; SMN2HPGDALDH1A1L3MBTL1KDM4E
SCHEMBL12377892 0.78 AOC3 (0.62) SMN1; SMN2HPGDAOC3ALDH1A1L3MBTL1
SCHEMBL29576128 0.76 ME2 (0.60) HPGDAOC3ALDH1A1L3MBTL1GAA
SCHEMBL1630859 0.76 L3MBTL1 (0.58) SMN1; SMN2HPGDAOC3ALDH1A1L3MBTL1
SCHEMBL11930058 0.75 SMN1; SMN2 (0.80) SMN1; SMN2HPGDALDH1A1GAAHSD17B10
SCHEMBL18711280 0.75 PANK3 (0.60) HPGDAOC3ALDH1A1L3MBTL1GAA
SCHEMBL1630856 0.75 ALDH1A1 (0.56) SMN1; SMN2HPGDAOC3ALDH1A1L3MBTL1
SCHEMBL20804512 0.75 ALDH1A1 (0.56) SMN1; SMN2HPGDAOC3ALDH1A1L3MBTL1
SCHEMBL30434376 0.75 AKR1C3 (0.66) HPGDAOC3ALDH1A1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9624229-B2 Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases RIGEL PHARMACEUTICALS, INC. (US) 2017-04-18 — — US disclosed
Send feedback